Aggregated
53% success rate- Bullish
- 0
- Hold
- 2
- Bearish
- 0
Truist Securities
A Truist Securities analyst with 27 tracked ratings across 14 distinct tickers has a 52.9% success rate on the captured sample, focusing on both sources while holding 2 ratings in one category and 6 in another.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| BTMD | 2026-04-16 | buy | $4.00 | Aggregated |
| ANIP | 2025-10-09 | hold | $90.00 | Aggregated |
| ANIPANI PHARMACEUTICALS INC | 2025-10-09 | hold | $90.00 | Aggregated |
| JAZZ | 2025-08-28 | buy | $205.00 | Aggregated |
| ANIP | 2025-08-11 | hold | $77.00 | Aggregated |
| ANIP | 2025-04-21 | hold | $65.00 | Aggregated |
| ANIP | 2024-10-22 | hold | $62.00 | Aggregated |
| ANIP | 2024-09-11 | hold | $60.00 | Aggregated |
| BHC | 2024-07-25 | hold | $7.00 | Aggregated |
| XAIR | 2024-04-30 | buy | $8.00 | Aggregated |
| XAIRBEYOND AIR INC | 2024-04-30 | unknown | $8.00 | Aggregated |
| BTMD | 2024-01-18 | buy | $9.00 | Aggregated |
| BTMDBIOTE CORP - ORDINARY SHARES - CLASS A | 2024-01-18 | unknown | $9.00 | Aggregated |
| XAIR | 2023-11-14 | buy | $10.00 | Aggregated |
| AMRX | 2023-11-08 | buy | $7.00 | Aggregated |
| AMRXAMNEAL PHARMACEUTICALS INC - ORDINARY SHARES - CLASS A | 2023-11-08 | unknown | $7.00 | Aggregated |
| AMRX | 2023-09-06 | buy | $6.00 | Aggregated |
| AMRX | 2023-08-07 | buy | $6.00 | Aggregated |
| XAIR | 2023-07-21 | buy | $14.00 | Aggregated |
| NVCRNOVOCURE LTD | 2023-06-06 | unknown | $95.00 | Aggregated |
| AMRX | 2023-03-29 | buy | $4.00 | Aggregated |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 2023-03-29 | unknown | $45.00 | Aggregated |
| CORTCORCEPT THERAPEUTICS INC | 2022-11-08 | hold | $28.00 | Aggregated |
| BTMD | 2022-09-27 | buy | $10.00 | Aggregated |
| XAIR | 2022-06-29 | buy | $20.00 | Aggregated |
| EOLSEVOLUS INC | 2022-01-20 | unknown | $11.00 | Aggregated |
| XAIR | 2021-11-12 | buy | $16.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| BTMD | 3 | 2026-04-16 | Aggregated |
| ANIP | 5 | 2025-10-09 | Aggregated |
| ANIPANI PHARMACEUTICALS INC | 1 | 2025-10-09 | Aggregated |
| JAZZ | 1 | 2025-08-28 | Aggregated |
| BHC | 1 | 2024-07-25 | Aggregated |
| XAIR | 5 | 2024-04-30 | Aggregated |
| XAIRBEYOND AIR INC | 1 | 2024-04-30 | Aggregated |
| BTMDBIOTE CORP - ORDINARY SHARES - CLASS A | 1 | 2024-01-18 | Aggregated |
| AMRX | 4 | 2023-11-08 | Aggregated |
| AMRXAMNEAL PHARMACEUTICALS INC - ORDINARY SHARES - CLASS A | 1 | 2023-11-08 | Aggregated |
| NVCRNOVOCURE LTD | 1 | 2023-06-06 | Aggregated |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 1 | 2023-03-29 | Aggregated |
| CORTCORCEPT THERAPEUTICS INC | 1 | 2022-11-08 | Aggregated |
| EOLSEVOLUS INC | 1 | 2022-01-20 | Aggregated |